Cláudia Chaves Loureiro

Benralizumab in severe eosinophilic asthma by previous biologic use and key clinical subgroups: real-world XALOC-1 programme

David J. Jackson, Girolamo Pelaia, Benjamin Emmanuel et al. · European Respiratory Journal · 2024 · 55 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Urinary metabolomic profiling of asthmatics can be related to clinical characteristics

Cláudia Chaves Loureiro, Amanda Santos de Oliveira, Marcele de Farias dos Santos et al. · Allergy · 2016 · 45 citations · Full text

Life Sciences, Biochemistry, Allergy +16

Feasibility and Acceptability of an Asthma App to Monitor Medication Adherence: Mixed Methods Study

Cristina Jácome, Rute Almeida, Ana Margarida Pereira et al. · JMIR mhealth and uhealth · 2021 · 40 citations · Full text

Pharmacy, Health Informatics, Consumer Health Informatics +11

Comparative effectiveness of <scp>anti‐IL5</scp> and <scp>anti‐IgE</scp> biologic classes in patients with severe asthma eligible for both

Paul Pfeffer, Nasloon Ali, Ruth Murray et al. · Allergy · 2023 · 24 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +16

Determinants of the Use of Health and Fitness Mobile Apps by Patients With Asthma: Secondary Analysis of Observational Studies

Ana Luísa Neves, Cristina Jácome, Tiago Taveira‐Gomes et al. · Journal of Medical Internet Research · 2021 · 23 citations · Full text

Nursing, Health Informatics, Health Services Research +10